Sectors

Federated Wireless secured the return of founding investor Allied Minds for a $13.7m extension that will expand wireless communications services forged on Virginia Tech research.

Boehringer Ingelheim Venture Fund co-led a series A round set to drive clinical work on UC Berkeley-founded Actym Therapeutics' immunotherapy pipeline.

Novo and Pivotal BioVenture Partners both invested as the lung disease therapy developer took its overall funding close to $100m.

The metal printing technology producer increased its total funding to $138m in a round led by Petronas-sponsored Piva that included TNSC.

The mobile frequency technology provider added $13.7m to an SBA Communications and American Tower-backed round now sized at $64.7m.

Boehringer Ingelheim Venture Fund co-led the cancer immunotherapy developer's series A round, which also featured Illumina Ventures.

The online insurance provider received $13.5m in a round led by Centauri Fund and backed by MassMutual Ventures, MDI Ventures and Central Capital Ventura.

Repeatome drug developer Rome Therapeutics is based on intellectual property from Massachusetts General Hospital and Icahn School of Medicine at Mount Sinai.

JHU-founded restorative materials technology developer Lifesprout secured $28.5m in a round led by Redmile Group as it looks to move into regenerative medicine.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The potential acquisition would reportedly value the HPE, Microsoft and Koch-backed cloud software provider below its most recent valuation but above $250m.